Understanding data exclusivity is crucial for life science companies and investors. Join US and EP patent attorneys from Goodwin and Kilburn & Strode as they clarify the complexities of data exclusivity for therapeutics.
Key discussion points include:
-
How data exclusivities differ between the US and EP
-
The origins and evolution of data exclusivity
-
How these regulations might change in the future
-
Strategies for leveraging data exclusivity with and without patent protection
We hope you can join us!
By registering, you consent to sharing your contact details with Kilburn & Strode and Goodwin.